Research News

September
20,
2022
| 07:00 AM America/Los_Angeles
Hispanic and Black patients are less likely than white patients to receive treatments known to cure a type of liver cancer called intrahepatic cholangiocarcinoma (iCCA), according to a new study by Cedars-Sinai Cancer investigators. Published
September
17,
2022
| 08:00 AM America/Los_Angeles
FINDINGSA study published today in the New England Journal of Medicine (NEJM) found that among patients with aortic stenosis undergoing transfemoral TAVR, the use of a debris capturing device called cerebral embolic protection reduced the risk of
September
15,
2022
| 08:02 AM America/Los_Angeles
FINDINGSA study published today in the Journal of the American College of Cardiology (JACC): Cardiovascular Imaging shows that artificial intelligence tools can more rapidly, and objectively, determine calcium scores in computed tomographic (CT) and
September
15,
2022
| 08:01 AM America/Los_Angeles
A novel clinical trial from Cedars-Sinai Cancer shows that active surveillance is an effective treatment for many low-risk thyroid cancer patients. The study, published in JAMA Oncology, also showed for the first time that patients who opted for
September
14,
2022
| 06:00 AM America/Los_Angeles
The Cedars-Sinai Department of Computational Biomedicine has received an $8 million grant from the National Institutes of Health to study Alzheimer’s disease. The research, led by Jason H. Moore, PhD, chair of the Department of Computational
September
12,
2022
| 10:00 AM America/Los_Angeles
Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study.Unlike colonoscopies, FIT doesn’t require lengthy preparation,
September
08,
2022
| 06:00 AM America/Los_Angeles
Racial and ethnic minorities in Los Angeles County are more likely to live as far as or farther than five miles from a cardiac rehabilitation facility, according to a new study by investigators at the Smidt Heart Institute at Cedars-Sinai. The
September
05,
2022
| 08:00 AM America/Los_Angeles
Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor
September
05,
2022
| 06:00 AM America/Los_Angeles
People in Los Angeles County experience differences in cancer risk and survival depending on a variety of factors such as race/ethnicity, gender, sexual orientation, geographic location and socioeconomic status, according to a new study by